Table:
begin	end	state
1	4	cytoplasmic
5	11	non-cytoplasmic
12	47	transmembrane
48	59	cytoplasmic
60	81	transmembrane
82	104	non-cytoplasmic
105	135	transmembrane
136	146	cytoplasmic
147	171	transmembrane
172	185	non-cytoplasmic
186	207	transmembrane
208	226	cytoplasmic
227	253	transmembrane
254	256	non-cytoplasmic
257	273	transmembrane
274	292	cytoplasmic
293	313	transmembrane
314	332	non-cytoplasmic
333	360	transmembrane
361	371	cytoplasmic
372	392	transmembrane
393	411	non-cytoplasmic
412	437	transmembrane
438	488	cytoplasmic

Input:
>Dsui_1262 FitnessBrowser__PS:Dsui_1262
MEFLINNMAPVMFGALVLFLLFGYPVAFALAANGMVFGFIGMELGLLHPALFQALPERVF
GIMANDTLLAIPFFTFMGLVLERSGMAEDLLDTIGQLFGPMRGGLAYAVIFVGALLAATT
GVVAASVISMGLISLPIMLRYGYDKRLASGVIAASGTLAQIIPPSLVLIIMADQLGKSVG
DMYEGAMVPGLILTSLYVGYVVILTLIKPNAAPALPLEARSLRGAKLLMRVLTSLVPPLV
LIFLVLGTIFMGIATPTEGGAMGASGALILALMRKRLSVSLLKQAMDTTAKLSSFVVFIL
VGSTVFGLVFRAVNGDLWVEHLLTSLPGGQLGFLIVVNILVFVLAFFLDFFELSFIIVPL
LGPVAEKLGIDLIWFGVLLGVNMQTSFMHPPFGFALFYLRSVAPASIKTTDIYWGAVPFV
CIQIIMVALIIIFPGIVSYGDPAHRAPTQQESEAMDLNSLMQQQEGEGGGSGEEGQNELL
KQLQQNSN

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server